JP Morgan Chase’s HUMANIGEN, INC. HGEN Stock Holding History

JP Morgan Chase’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-69	Closed	-$11	–	7871
2023 Q2	$11	Hold	69	–	–	﹤0.01%	6816
2023 Q1	$0	Hold	69	–	–	﹤0.01%	7418
2022 Q4	$0	Hold	69	–	–	﹤0.01%	7207
2022 Q3	$0	Hold	69	–	–	﹤0.01%	7027
2022 Q2	$0	Sell	69 -23,094	-100%	-$51.8K	﹤0.01%	7071
2022 Q1	$70K	Buy	23,163 +6,120	+36%	+$16.4K	﹤0.01%	5656
2021 Q4	$63K	Buy	17,043 +95	+0.6%	+$556	﹤0.01%	5860
2021 Q3	$100K	Sell	16,948 -15,365	-48%	-$216K	﹤0.01%	5570
2021 Q2	$562K	Buy	32,313 +17,313	+115%	+$316K	﹤0.01%	4620
2021 Q1	$287K	Buy	+15,000	New	+$274K	﹤0.01%	4994
2020 Q4	–	Sell	-1	Closed	–	–	6040
2020 Q3	$0	Buy	+1	New	+$10	﹤0.01%	5888

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

JP Morgan Chase's HGEN Position: Q3 2023 in Review

JP Morgan Chase sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 69 shares — an estimated $11 sold.

JP Morgan Chase first reported a position in HGEN in Q3 2020 and held it in 11 quarters. The position peaked at $562K in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

JP Morgan Chase reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
JP Morgan Chase sold 69 HUMANIGEN, INC. shares in Q3 2023, an estimated $11.
JP Morgan Chase first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 11 quarters.
JP Morgan Chase's HUMANIGEN, INC. position peaked at $562K in Q2 2021.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.